ストックスクリーナーアプリを入手
0.2637
1.50%
0.0039
アフターアワーズ：
.26
-0.0037
-1.40%
前日終値:
$0.2598
開ける：
$0.252
24時間の取引高:
1.48M
Relative Volume:
1.36
時価総額：
$16.16M
収益：
-
当期純損益:
$-17.78M
株価収益率:
-0.4802
EPS:
-0.5492
ネットキャッシュフロー:
$-10.52M
1週間 パフォーマンス:
-3.76%
1か月 パフォーマンス:
-28.79%
6か月 パフォーマンス:
-69.13%
1年 パフォーマンス:
-88.92%
1日の値動き範囲:
$0.25
$0.2663
1週間の範囲:
$0.24
$0.28
52週間の値動き範囲:
$0.24
$2.55
Fibrobiologics Inc Stock (FBLG) Company Profile
FBLG を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
FBLG
Fibrobiologics Inc
|
0.2637 | 15.94M | 0 | -17.78M | -10.52M | -0.5492 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.48 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
718.36 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.12 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
901.17 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.00 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Fibrobiologics Inc Stock (FBLG) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-12 | 開始されました | Rodman & Renshaw | Buy |
| 2024-10-30 | 開始されました | H.C. Wainwright | Buy |
| 2024-09-24 | 開始されました | Maxim Group | Buy |
Fibrobiologics Inc (FBLG) 最新ニュース
Will FibroBiologics Inc. (SG0) stock deliver stable dividendsRisk Management & Expert Approved Momentum Trade Ideas - Newser
FibroBiologics announces payoff of outstanding debt - MSN
Is FibroBiologics Inc. (SG0) stock good for long term investingQuarterly Growth Report & Technical Pattern Recognition Alerts - Newser
Is FibroBiologics Inc. stock dividend yield sustainableWeekly Trade Summary & Verified Momentum Watchlists - Newser
Is FibroBiologics Inc. (SG0) stock included in top ETFsIPO Watch & Risk Managed Investment Strategies - Newser
Prepare Yourself for Liftoff: FibroBiologics Inc (FBLG) - Setenews
Reviewing FibroBiologics (NASDAQ:FBLG) and Axsome Therapeutics (NASDAQ:AXSM) - Defense World
Will FibroBiologics Inc. stock gain from strong economyJuly 2025 Closing Moves & Technical Buy Zone Confirmations - BỘ NỘI VỤ
FibroBiologics repays convertible notes, eliminating dilution risk By Investing.com - Investing.com Nigeria
FibroBiologics Announces Payoff of Outstanding Debt - The Manila Times
FibroBiologics repays convertible notes, eliminating dilution risk - Investing.com
FibroBiologics (Nasdaq: FBLG) retires $15M Yorkville notes, keeps access to $25M SEPA - Stock Titan
FibroBiologics closes $1.5 million registered direct offering By Investing.com - Investing.com Nigeria
Fibrobiologics announces closing of $1.5 million registered direct offering priced at-the-market under Nasdaq rules - marketscreener.com
FibroBiologics Closes $1.5 Million Registered Direct Share Offering - marketscreener.com
FibroBiologics closes $1.5 million registered direct offering - Investing.com
FibroBiologics Announces Closing of $1.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - GlobeNewswire
FibroBiologics Announces Securities Purchase Agreement - TipRanks
FibroBiologics raises $1.5 million in registered direct offering By Investing.com - Investing.com Nigeria
Fibrobiologics stock tumbles after $1.5 million direct offering By Investing.com - Investing.com Nigeria
Fibrobiologics stock tumbles after $1.5 million direct offering - Investing.com
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
FibroBiologics prices 4.48M shares at 33.5c in registered direct offering - TipRanks
FibroBiologics Announces $1.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - The Manila Times
FibroBiologics raises $1.5 million in registered direct offering - Investing.com
FibroBiologics (Nasdaq: FBLG) prices $1.5M direct offering at $0.335 with private warrants - Stock Titan
Will Naga Dhunseri Group Limited Stock Benefit From Industry Trends in YEARMarket Liquidity Analysis & Access Risk Ratings for Every Stock - earlytimes.in
FibroBiologics Inc Stock Analysis and ForecastHigh Yield Income Stocks & Capital Planning and Optimization - earlytimes.in
HC Wainwright & Co. Maintains FibroBiologics (FBLG) Buy Recommendation - MSN
Fibrobiologics receives Australian HREC approvals for CYWC-628 - BioWorld MedTech
FibroBiologics announces $25 million financing - MSN
Will FibroBiologics Inc. (SG0) stock outperform value peersJuly 2025 Selloffs & Smart Swing Trading Techniques - newser.com
FibroBiologics (FBLG) Price Target Decreased by 14.63% to 8.92 - MSN
When is the best time to exit FibroBiologics Inc.Portfolio Return Summary & Safe Entry Momentum Tips - newser.com
D. Boral Capital Maintains FibroBiologics (FBLG) Buy Recommendation - Nasdaq
FibroBiologics prices 3.54M shares at 33c in registered direct offering - MSN
[424B5] FibroBiologics, Inc. Prospectus Supplement (Debt Securities) - Stock Titan
FibroBiologics (FBLG) Analyst Ratings: D. Boral Capital Maintains Buy | FBLG Stock News - GuruFocus
FibroBiologics Receives HREC Approval for Phase 1/2 Clinical Trial for CYWC628 for the Treatment of Refractory Diabetic Foot Ulcers - The Manila Times
Fibrobiologics receives HREC approval for phase 1/2 clinical trial for CYWC628 for the treatment of refractory diabetic foot ulcers - MarketScreener
FibroBiologics Receives HREC Approval for Phase 1/2 - GlobeNewswire
Brag House and FibroBiologics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Oak Ridger
How FibroBiologics Inc. (SG0) stock trades in high volatilityEarnings Summary Report & Intraday High Probability Setup Alerts - newser.com
FibroBiologics closes $4 million registered direct offering By Investing.com - Investing.com Nigeria
FibroBiologics closes $4 million registered direct offering - Investing.com
Fibrobiologics Inc (FBLG) 財務データ
収益
当期純利益
現金流量
EPS
1.44%
0.91%
大文字化:
|
ボリューム (24 時間):